1701 - 1750 of 8587 Results
Title
Year
-
OPENTitle: Neuropathologic features of TOMM40 '523 variant on late‐life cognitive declineJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 12Start Page: 1380End Page: 1388Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.05.002Best OA location URL: http://doi.org/10.1016/j.jalz.2017.05.002Citation Count: 24
-
OPENTitle: Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population‐based elderly cohortJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 12Issue #: 12Start Page: 1226End Page: 1234Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2016.06.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5148697Citation Count: 127
- Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases2017OPENTitle: Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseasesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 3Start Page: 352End Page: 366Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2017.09.012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2017.09.012Citation Count: 140
-
OPENTitle: The Relationship Between Mobility Dysfunction Staging and Global Cognitive PerformanceJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 30Issue #: 3Start Page: 230End Page: 236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000136Best OA location URL: http://doi.org/10.1097/WAD.0000000000000136Citation Count: 29
-
OPENTitle: Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal DementiaJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 1Start Page: 73End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000161Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5322244Citation Count: 67
-
OPENTitle: Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 3Issue #: 1Start Page: 51End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.002Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2016.03.002Citation Count: 79
-
OPENTitle: Bayesian latent time joint mixed‐effects model of progression in the Alzheimer's Disease Neuroimaging InitiativeJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 10Issue #: 1Start Page: 657End Page: 668Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2018.07.008Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2018.07.008Citation Count: 22
-
OPENTitle: The Quick Dementia Rating System (QDRS): A rapid dementia staging toolJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 1Issue #: 3Start Page: 249End Page: 259Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2015.03.003Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2015.03.003Citation Count: 155
-
OPENTitle: Improving the clinical detection of Lewy body dementia with the Lewy body composite risk scoreJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 1Issue #: 3Start Page: 316End Page: 324Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2015.05.004Best OA location URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.dadm.2015.05.004Citation Count: 74
-
RESTRICTEDTitle: Proteomics of human cerebrospinal fluid – the good, the bad, and the uglyJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 1Issue #: 8Start Page: 805End Page: 819Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/prca.200700081Citation Count: 57
-
OPENTitle: Neuronal gene expression correlates of Parkinson's disease with dementiaJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 11Start Page: 1588End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22184Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2666445Citation Count: 47
-
OPENTitle: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Journal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 1345End Page: 1358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.049551Best OA location URL: http://doi.org/10.1124/mol.108.049551Citation Count: 185
-
OPENTitle: Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBVJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 24Issue #: 3Start Page: 322End Page: 327Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0130-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6363916Citation Count: 64
-
OPENTitle: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 1490End Page: 1495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2010.114Best OA location URL: http://www.cell.com/article/S1525001616310991/pdfCitation Count: 80
-
OPENTitle: Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine ModelJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 544End Page: 554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.216Best OA location URL: http://www.cell.com/article/S1525001616305111/pdfCitation Count: 30
-
OPENTitle: Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 1048End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.11Best OA location URL: http://www.cell.com/article/S1525001616319098/pdfCitation Count: 139
-
OPENTitle: Long-term Transgene Expression in the Central Nervous System Using DNA NanoparticlesJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 641End Page: 650Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.2Best OA location URL: http://www.cell.com/article/S152500161631557X/pdfCitation Count: 77
-
OPENTitle: Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 2169End Page: 2180Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2013.169Best OA location URL: http://www.cell.com/article/S1525001616309431/pdfCitation Count: 55
-
OPENTitle: Highlights of the Stockholm Congress: A Clinician's PerspectiveJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 277End Page: 279Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12093Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12093Citation Count: 0
-
OPENTitle: Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate BrainJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 3Start Page: 588End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.286Best OA location URL: http://www.cell.com/article/S1525001616323085/pdfCitation Count: 125
-
OPENTitle: Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 1572End Page: 1579Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2008.146Best OA location URL: http://www.cell.com/article/S1525001616320548/pdfCitation Count: 116
- Failure of Sequential Pallidal and Motor Thalamus DBS for Rapid‐Onset Dystonia‐Parkinsonism (DYT12)2017OPENTitle: Failure of Sequential Pallidal and Motor Thalamus DBS for Rapid‐Onset Dystonia‐Parkinsonism (DYT12)Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 444End Page: 445Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12559Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12559Citation Count: 11
-
OPENTitle: Heritability of the shape of subcortical brain structures in the general populationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms13738Best OA location URL: https://www.nature.com/articles/ncomms13738.pdfCitation Count: 98
-
OPENTitle: Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12104Citation Count: 3
-
OPENTitle: Structure-guided mutagenesis reveals a hierarchical mechanism of Parkin activationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms14697Best OA location URL: https://www.nature.com/articles/ncomms14697.pdfCitation Count: 105
-
OPENTitle: Phosphorylation of LAMP2A by p38 MAPK couples ER stress to chaperone-mediated autophagyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-017-01609-xBest OA location URL: https://www.nature.com/articles/s41467-017-01609-x.pdfCitation Count: 123
-
OPENTitle: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms10332Best OA location URL: https://www.nature.com/articles/ncomms10332.pdfCitation Count: 92
-
OPENTitle: Atypical presentation of late‐onset Tay‐sachs diseaseJournal Name: Muscle & NervePublisher: WileyVol: 49Issue #: 5Start Page: 768End Page: 771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mus.24146Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4346308Citation Count: 37
-
OPENTitle: Expert Testimony at the Food and Drug Administration: Who Wants the Truth?Journal Name: Narrative Inquiry in BioethicsPublisher: Project MUSEVol: 1Issue #: 2Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1353/nib.2011.0046Best OA location URL: https://europepmc.org/articles/pmc4528642?pdf=renderCitation Count: 0
-
OPENTitle: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2Journal Name: Nature Chemical BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 203End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nchembio.538Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3287420Citation Count: 421
-
OPENTitle: Widespread sex differences in gene expression and splicing in the adult human brainJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms3771Best OA location URL: https://www.nature.com/articles/ncomms3771.pdfCitation Count: 294
-
OPENTitle: Hyperplasticity in Autism Spectrum Disorder confers protection from Alzheimer’s diseaseJournal Name: Medical HypothesesPublisher: Elsevier BVVol: 83Issue #: 3Start Page: 337End Page: 342Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.mehy.2014.06.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4392915Citation Count: 46
-
OPENTitle: Repeatability of Aerobic Capacity Measurements in Parkinson DiseaseJournal Name: Medicine & Science in Sports & ExercisePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 43Issue #: 12Start Page: 2381End Page: 2387Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1249/mss.0b013e31822432d4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3701959Citation Count: 45
-
OPENTitle: Osteopontin Expression in the Brain Triggers Localized Inflammation and Cell Death When Immune Cells Are Activated by Pertussis ToxinJournal Name: Mediators of InflammationPublisher: WileyVol: 2014Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/358218Best OA location URL: https://downloads.hindawi.com/journals/mi/2014/358218.pdfCitation Count: 10
-
OPENTitle: Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s DiseaseJournal Name: MetabolitesPublisher: MDPI AGVol: 8Issue #: 4Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo8040071Best OA location URL: https://www.mdpi.com/2218-1989/8/4/71/pdfCitation Count: 51
-
OPENTitle: Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem CellsJournal Name: Methods in Molecular BiologyPublisher: Humana PressVol:Issue #:Start Page: 355End Page: 366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-60761-369-5_19Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2948208Citation Count: 97
-
OPENTitle: Isolation of Murine Postnatal Brain Microglia for Phenotypic Characterization Using Magnetic Cell Separation TechnologyJournal Name: Methods in Molecular BiologyPublisher: Humana PressVol:Issue #:Start Page: 33End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-62703-520-0_5Best OA location URL: http://doi.org/10.1007/978-1-62703-520-0_5Citation Count: 22
-
OPENTitle: Two-Pore Channels and Parkinson's Disease: Where's the Link?Journal Name: MessengerPublisher: American Scientific PublishersVol: 5Issue #: 1Start Page: 67End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1166/msr.2016.1051Citation Count: 7
-
OPENTitle: Combined Optogenetic and Chemogenetic Control of NeuronsJournal Name: Methods in Molecular BiologyPublisher: Springer New YorkVol:Issue #:Start Page: 207End Page: 225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-4939-3512-3_14Citation Count: 32
-
OPENTitle: Membrane proteins in four acts: Function precedes structure determinationJournal Name: MethodsPublisher: Elsevier BVVol: 55Issue #: 4Start Page: 415End Page: 420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ymeth.2011.11.001Best OA location URL: https://europepmc.org/articles/pmc3282554?pdf=renderCitation Count: 9
-
OPENTitle: Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic ProteinsJournal Name: Methods in Molecular BiologyPublisher: Springer New YorkVol:Issue #:Start Page: 369End Page: 386Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-4939-7811-3_24Best OA location URL: https://escholarship.org/content/qt3cw060nv/qt3cw060nv.pdf?t=qi74efCitation Count: 17
-
OPENTitle: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 10Start Page: 978End Page: 988Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3879782Citation Count: 261
-
OPENTitle: Hypercholinergic activity in LRRK2 Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 290End Page: 291Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30073-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5858987Citation Count: 6
-
OPENTitle: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-xCitation Count: 663
-
OPENTitle: Sequential Voluntary Cough and Aspiration or Aspiration Risk in Parkinson’s DiseaseJournal Name: LungPublisher: Springer Science and Business Media LLCVol: 192Issue #: 4Start Page: 601End Page: 608Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00408-014-9584-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4740922Citation Count: 88
-
OPENTitle: Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodiesJournal Name: mAbsPublisher: Informa UK LimitedVol: 4Issue #: 6Start Page: 686End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.4161/mabs.21696Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/mabs.21696?needAccess=trueCitation Count: 68
-
OPENTitle: Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free AssaysJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 126Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/55361Best OA location URL: https://www.jove.com/pdf/55361/recombinant-synucleins-stimulate-protein-phosphatase-2a-catalyticCitation Count: 7
-
OPENTitle: Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adult Life SpanJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 742End Page: 742Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4051849Citation Count: 39
-
OPENTitle: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 2Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3940333Citation Count: 225
-
OPENTitle: APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 11Start Page: 1405End Page: 1405Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1455Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/1900308/noi140049.pdfCitation Count: 189